NCT04990128View on ClinicalTrials.gov

Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip Osteoarthritis

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

August 31, 2027

Conditions
Hip Osteoarthritis
Interventions
COMBINATION_PRODUCT

Aspire Needle + Emcyte PureBMC

The Aspire Needle will be utilized to extract the bone marrow and the Emcyte PureBMC will be used to concentrate bone marrow aspirate. The final concentrate will be injected into the hip.

DRUG

Triamcinolone

40 mg (1 mL) triamcinolone and 4 cc of lidocaine 1% that will be injected into the hip.

Trial Locations (1)

33331

Cleveland Clinic Florida, Weston

All Listed Sponsors
collaborator

Lisa Dean Moseley Foundation

UNKNOWN

lead

The Cleveland Clinic

OTHER